{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-05T19:51:08.787997+00:00","company":{"ticker":"HOOK","cik":1760542,"company_name":"HOOKIPA Pharma Inc."},"pagination":{"limit":100,"returned":10,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"executive_change","fact_key":"0febfd009e","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-08-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-08-30","interim":false,"role":"non-executive chair","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Julie O'Neill was appointed as non-executive chair at HOOKIPA Pharma Inc..","evidence_excerpt":"the Company’s board of directors (the “Board”) appointed Julie O’Neill to serve as non-executive chair of the Board, effective as of the Effective Time.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-095236","anchor_url":"https://secwatch.observer/filing/0001104659-24-095236#claim-0febfd009e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm"},{"fact_type":"executive_change","fact_key":"c02622ea4b","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-08-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-08-30","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Timothy Reilly resigned as director at HOOKIPA Pharma Inc..","evidence_excerpt":"On August 27, 2024, Timothy Reilly, Ph.D., notified the Company of his resignation as a director of the Company, effective as of the Effective Time.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-095236","anchor_url":"https://secwatch.observer/filing/0001104659-24-095236#claim-c02622ea4b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm"},{"fact_type":"executive_change","fact_key":"400c6ec2e3","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-08-30T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-08-30","interim":false,"role":"director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jan van de Winkel resigned as director at HOOKIPA Pharma Inc..","evidence_excerpt":"On August 27, 2024, Jan van de Winkel, Ph.D., notified HOOKIPA Pharma Inc. (the “Company”) of his resignation as a director of the Company, effective as of August 30, 2024 at 12:00 p.m. Eastern Time","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-095236","anchor_url":"https://secwatch.observer/filing/0001104659-24-095236#claim-400c6ec2e3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm"},{"fact_type":"executive_change","fact_key":"42501d517e","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-07-26T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-22","interim":false,"role":"Chief Executive Officer and President","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Malte Peters was appointed as Chief Executive Officer and President at HOOKIPA Pharma Inc..","evidence_excerpt":"the Company’s board of directors (the “Board”) appointed Malte Peters, M.D., as the Company’s Chief Executive Officer and President, effective July 22, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-083019","anchor_url":"https://secwatch.observer/filing/0001104659-24-083019#claim-42501d517e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm"},{"fact_type":"executive_change","fact_key":"5b92f3f04d","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-07-26T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Reinhard Kandera resigned as Director at HOOKIPA Pharma Inc..","evidence_excerpt":"Mr. Kandera also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Financial Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-083019","anchor_url":"https://secwatch.observer/filing/0001104659-24-083019#claim-5b92f3f04d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm"},{"fact_type":"executive_change","fact_key":"4f4e8f4513","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-07-26T23:59:59+00:00","payload":{"action":"separated","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-22","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Reinhard Kandera departed as Chief Financial Officer at HOOKIPA Pharma Inc..","evidence_excerpt":"On July 22, 2024, Reinhard Kandera separated as the Chief Financial Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-083019","anchor_url":"https://secwatch.observer/filing/0001104659-24-083019#claim-4f4e8f4513","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm"},{"fact_type":"executive_change","fact_key":"723322b78a","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-07-26T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-23","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Joern Aldag resigned as Director at HOOKIPA Pharma Inc..","evidence_excerpt":"Mr. Aldag also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Executive Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-083019","anchor_url":"https://secwatch.observer/filing/0001104659-24-083019#claim-723322b78a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm"},{"fact_type":"executive_change","fact_key":"6e308d7dce","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-07-26T23:59:59+00:00","payload":{"action":"separated","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-22","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Malte Peters","successor_named":true},"claim":"Joern Aldag departed as Chief Executive Officer at HOOKIPA Pharma Inc..","evidence_excerpt":"On July 22, 2024, Joern Aldag separated as the Chief Executive Officer of HOOKIPA Pharma Inc. (the “Company”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-24-083019","anchor_url":"https://secwatch.observer/filing/0001104659-24-083019#claim-6e308d7dce","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000110465924083019/0001104659-24-083019-index.htm"},{"fact_type":"earnings_release","fact_key":"aea56e19247eab0a0d26a35d98fb54cd083fb952","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-05-09T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"first quarter ended March 31, 2024","report_date":"2024-05-09","result_type":"reported_results","revenue_text":"$36.6 million"},"claim":"HOOKIPA Pharma Inc. reported first quarter ended March 31, 2024 results: revenue $36.6 million.","evidence_excerpt":"Revenue was $36.6 million for the three months ended March 31, 2024, compared to $3.2 million for the same period in 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001558370-24-007462","anchor_url":"https://secwatch.observer/filing/0001558370-24-007462#claim-aea56e19247eab0a0d26a35d98fb54cd083fb952","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000155837024007462/0001558370-24-007462-index.htm"},{"fact_type":"earnings_release","fact_key":"f969b40b7cc27734aed1273d71836847c6aab299","cik":1760542,"ticker":"HOOK","company_name":"HOOKIPA Pharma Inc.","filed_at":"2024-03-22T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the fourth quarter and full year 2023","report_date":"2024-03-22","result_type":"reported_results","revenue_text":null},"claim":"HOOKIPA Pharma Inc. reported financial results for the fourth quarter and full year 2023.","evidence_excerpt":"On March 22, 2024, HOOKIPA Pharma Inc. (the “Company”) announced Financial Results for the Fourth Quarter and Full Year 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001558370-24-003735","anchor_url":"https://secwatch.observer/filing/0001558370-24-003735#claim-f969b40b7cc27734aed1273d71836847c6aab299","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760542/000155837024003735/0001558370-24-003735-index.htm"}]}